HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kate Newberry Selected Research

Kate Newberry Research Topics

Disease

4Primary Myelofibrosis (Myelosclerosis)
01/2017 - 09/2014
3Neoplasms (Cancer)
10/2021 - 08/2013
2Leukemia
01/2017 - 03/2015
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2014 - 08/2013
1Disease Progression
10/2021
1Thrombocytosis (Thrombocythemia)
01/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2015
1Anemia
09/2014
1Multiple Myeloma
06/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013

Drug/Important Bio-Agent (IBA)

2Janus KinasesIBA
01/2017 - 03/2015
2Lenalidomide (CC 5013)FDA Link
08/2015 - 06/2014
2ruxolitinibIBA
08/2015 - 03/2015
1avapritinibIBA
10/2021
1regorafenibIBA
10/2021
1Tyrosine Kinase InhibitorsIBA
10/2021
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2021
1Janus Kinase 2IBA
01/2017
1CalreticulinIBA
01/2017
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2015
1pomalidomideIBA
09/2014
1Hemoglobins (Hemoglobin)IBA
09/2014
1Prednisone (Sone)FDA LinkGeneric
09/2014
1ibrutinibIBA
08/2013
1Agammaglobulinaemia Tyrosine KinaseIBA
08/2013

Therapy/Procedure

3Therapeutics
01/2017 - 09/2014